Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inside Therapeutics
Paris, Franceinsidetx.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Inside Therapeutics develops and commercializes advanced microfluidic platforms for rapid, scalable lipid nanoparticle (LNP) and RNA-LNP formulation. Their TAMARA system enables researchers to efficiently formulate nanoparticles from discovery through in vivo testing with high yield, precise size control, and minimal reagent waste. The technology accelerates the development of nanomedicine products such as RNA vaccines and therapeutics.
- Modalities
- Lipid nanoparticle delivery therapyNanoparticleRNA-based drugs (enabling technology, not direct developer)
- Industry
- Drug Discovery Services
02
Partnerships
OSE Immunotherapeutics (user/testimonial)Eden TechCherry Biotech
Beyond the preview
Go deeper on Inside Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Inside Therapeutics.